What Happened?
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 4.5% in the morning session after Piper Sandler raised its price target on the company's stock to $165 from $135. The investment firm also maintained its positive "Overweight" rating. The decision was based on improved reimbursement news for the company, which makes technology to treat sleep apnea. The analyst noted that better insurance coverage should help drive more sales and lead to higher average selling prices for Inspire's products.
After the initial pop the shares cooled down to $143.65, up 5% from previous close.
Is now the time to buy Inspire Medical Systems? Access our full analysis report here.
What Is The Market Telling Us
Inspire Medical Systems’s shares are extremely volatile and have had 32 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 6 days ago when the stock gained 5.3% on the news that the stock's positive momentum continued as Morgan Stanley raised its price target. Investors seemed to focus on the positive aspect of the analyst's note, which was the increased price target to $130 from $105. This suggested that despite the more neutral rating, the firm saw a higher potential valuation for the company's shares than it did before.
Inspire Medical Systems is down 24.1% since the beginning of the year, and at $143.65 per share, it is trading 33.3% below its 52-week high of $215.42 from January 2025. Investors who bought $1,000 worth of Inspire Medical Systems’s shares 5 years ago would now be looking at an investment worth $723.24.
While Wall Street chases Nvidia at all-time highs, an under-the-radar semiconductor supplier is dominating a critical AI component these giants can’t build without. Click here to access our full research report.